MarketWatch
GoodRx stock tumbles 30% after Q4 miss
Shares of GoodRx Holdings Inc. fell more than 30% in the extended session Monday after the health care company reported adjusted quarterly earnings below Wall Street expectations and sales also disappointed. The company said it lost $39.9 million, or 10 cents a share, in the fourth quarter, compared with a loss of $298.3 million, or 74 cents a share, in the year-ago period. Adjusted for one-time items, GoodRx earned 9 cents a share. Revenue rose 39% to $213.3 million, the company said. Analysts
